Related Experiment Video
Updated: May 23, 2025

Guidelines and Experience Using Imaging Biomarker Explorer IBEX for Radiomics
Published on: January 8, 2018
A Benchmark, Expand, and Calibration (BenchExCal) Trial Emulation Approach for Using Real-World Evidence to Support
Shirley V Wang1, Massimiliano Russo1,2, Robert J Glynn1
1Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
This study introduces a novel BenchExCal approach using real-world evidence from healthcare databases to enhance drug effectiveness evaluations and support new drug indications.
Area of Science:
- Pharmacovigilance and Drug Effectiveness Research
- Real-World Evidence (RWE) in Regulatory Science
- Comparative Effectiveness Research
Background:
- Real-world evidence (RWE) from healthcare databases is crucial for post-market drug safety and effectiveness evaluations.
- Advancements in methods and infrastructure support RWE use for effectiveness claims, including expanding drug indications.
- Current methods for using database studies to support indication expansions require enhanced confidence in validity.
Purpose of the Study:
- To propose and evaluate a structured benchmarking and calibration approach (BenchExCal) for trial emulation using RWE.
- To increase confidence in findings from database studies supporting drug indication expansions.
- To provide insights for interpreting RWE in the context of hypothetical trials for new indications.
Main Methods:
- The study proposes the Benchmark, Expand, and Calibration (BenchExCal) approach for trial emulation.
- The approach involves benchmarking an initial database study against existing Randomized Controlled Trial (RCT) evidence.
- Subsequent database studies are calibrated based on observed differences between the initial RCT and database study results.
Main Results:
- The BenchExCal approach aims to increase confidence in RWE for supporting expanded drug indications.
- Simulation studies and five planned empirical examples will evaluate the performance of the BenchExCal approach.
- The project will offer insights into using first-stage benchmarking to calibrate second-stage emulations for new indications.
Conclusions:
- The BenchExCal approach offers a structured method to enhance the reliability of RWE for regulatory decision-making.
- This methodology can improve the interpretation of database study findings for drug indication expansions.
- Further research is needed to address all clinical and data scenarios encountered in supplemental indication seeking.
Related Concept Videos
Clinical Trials: Overview
Data Collection by Experiments
An example of the experimental method is a public...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Bioequivalence: Overview
Crossover Experiments
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

